FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
Miller Robert E
  2. Issuer Name and Ticker or Trading Symbol
Sonoma Pharmaceuticals, Inc. [SNOA]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
_____ Officer (give title below) __X__ Other (specify below)
Former CFO
(Last)
(First)
(Middle)
C/O SONOMA PHARMACEUTICALS, INC., 1129 N. MCDOWELL BLVD.
3. Date of Earliest Transaction (Month/Day/Year)
01/14/2019
(Street)

PETALUMA, CA 94954
4. If Amendment, Date Original Filed(Month/Day/Year)
6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)
7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common Stock               20,800 D  
Common Stock               18,868 I (1) See Note 1

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)
6. Date Exercisable and Expiration Date
(Month/Day/Year)
7. Title and Amount of Underlying Securities
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)
11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock option (right to buy) $ 38.15 01/14/2019   H     5,271   (2) 01/14/2019 Common Stock 5,271 (3) 203,800 D  
Stock option (right to buy) $ 68.95 01/14/2019   H     5,357   (2) 01/14/2019 Common Stock 5,357 (4) 198,443 D  
Stock option (right to buy) $ 70.35 01/14/2019   H     357   (2) 01/14/2019 Common Stock 357 (5) 198,086 D  
Stock option (right to buy) $ 56 01/14/2019   H     5,000   (2) 01/14/2019 Common Stock 5,000 (6) 193,086 D  
Stock option (right to buy) $ 43.75 01/14/2019   H     1,785   (2) 01/14/2019 Common Stock 1,785 (7) 191,301 D  
Stock option (right to buy) $ 32.55 01/14/2019   H     4,285   (2) 01/14/2019 Common Stock 4,285 (8) 187,016 D  
Stock option (right to buy) $ 14.85 01/14/2019   H     5,351   (2) 01/14/2019 Common Stock 5,351 (9) 181,665 D  
Stock option (right to buy) $ 19.5 01/14/2019   H     26,020   (2) 01/14/2019 Common Stock 26,020 (10) 155,645 D  
Stock option (right to buy) $ 5.8 01/14/2019   H     7,912   (2) 01/14/2019 Common Stock 7,912 (11) 147,733 D  
Stock option (right to buy) $ 4.81 01/14/2019   H     50,000   (2) 01/14/2019 Common Stock 50,000 (12) 97,733 D  
Stock option (right to buy) $ 7.06 01/14/2019   H     30,000   (2) 01/14/2019 Common Stock 30,000 (13) 67,733 D  
Stock option (right to buy) $ 2.41 01/14/2019   H     67,733   (2) 01/14/2019 Common Stock 67,733 (14) 0 D  

Reporting Owners

Reporting Owner Name / Address Relationships
 Director  10% Owner  Officer  Other
Miller Robert E
C/O SONOMA PHARMACEUTICALS, INC.
1129 N. MCDOWELL BLVD.
PETALUMA, CA 94954
      Former CFO

Signatures

 /s/ Robert E. Miller   01/15/2019
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) The shares are owned by Mr. Miller as trustee for The Miller 2005 Grandchildren's Trust, for which Mr. Miller and his wife, Margaret I. Miller, are the trustees.
(2) The stock options expired on January 14, 2019 in connection with the Separation and Mutual Release Agreement between the Issuer and Mr. Miller, dated December 13, 2018.
(3) The stock options were originally granted on March 10, 2009.
(4) The stock options were originally granted on June 7, 2010 pursuant to the Issuer's 2010 Bonus Plan.
(5) The stock options were originally granted on March 31, 2011 pursuant to the Issuer's 2010 Bonus Plan in lieu of cash.
(6) The stock options were originally granted on June 16, 2011 pursuant to the Issuer's 2011 Bonus Plan in lieu of cash.
(7) The stock options were originally granted on March 7, 2012 pursuant to the Issuer's 2011 Bonus Plan in lieu of cash.
(8) The stock options were originally granted on August 24, 2012 pursuant to the Issuer's 2012 Bonus Plan in lieu of cash.
(9) The stock options were originally granted on September 19, 2013 pursuant to the Issuer's 2013 Bonus Plan in lieu of cash.
(10) The stock options were originally granted on March 4, 2014 as compensation in lieu of cash.
(11) The stock options were originally granted on August 21, 2015 for the achievement of target milestones in fiscal year ended March 31, 2016.
(12) The stock options were originally granted on November 30, 2016 as a signing bonus for his employment agreement, dated November 30, 2016.
(13) The stock options were originally granted on April 3, 2017 in connection with his service as the Issuer's CFO.
(14) The stock options were originally granted on July 20, 2018 as a bonus for fiscal year 2018.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.